$CMRX
CHIMERIX INC Stock $cmrx

$cmrx Overview Financials Valuation SEC Filings Company Website

2016 Q4 Form 10-Q Financial Statement

#000111748016000056 Filed on November 07, 2016

Income Statement

Concept	2016 Q4	2016 Q3	2015 Q3
Revenue	$1.980M	$653.0K	$2.271M
YoY Change	-36.33%	-71.25%	91.65%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$5.650M	$5.830M	$8.613M
YoY Change	-42.11%	-32.31%	82.59%
% of Gross Profit
Research & Development	$11.71M	$12.25M	$26.50M
YoY Change	-62.92%	-53.78%	98.79%
% of Gross Profit
Depreciation & Amortization	$280.0K	$250.0K	$180.0K
YoY Change	27.27%	38.89%	125.0%
% of Gross Profit
Operating Expenses	$17.35M	$18.07M	$35.02M
YoY Change	-58.02%	-48.39%	94.06%
Operating Profit	-$15.37M	-$17.42M	-$32.75M
YoY Change	-59.78%	-46.8%	94.23%
Interest Expense	$420.0K	$400.0K	$300.0K
YoY Change	10.53%	33.33%	-433.33%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$14.96M	-$17.03M	-$32.45M
YoY Change	-60.47%	-47.52%	91.45%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$14.96M	-$17.03M	-$32.45M
YoY Change	-60.48%	-47.53%	91.43%
Net Earnings / Revenue	-755.4%	-2607.2%	-1428.84%
Basic Earnings Per Share
Diluted Earnings Per Share	-$322.2K	-$368.3K	-$704.5K
COMMON SHARES
Basic Shares Outstanding	46.32M shares	46.21M shares	46.07M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2016 Q4	2016 Q3	2015 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$232.0M	$249.7M	$220.8M
YoY Change	5.31%	13.09%	17.2%
Cash & Equivalents	$51.46M	$49.36M	$44.72M
Short-Term Investments	$180.6M	$200.3M	$176.1M
Other Short-Term Assets	$841.0K	$4.300M	$8.200M
YoY Change	-1.18%	-47.56%	134.29%
Inventory
Prepaid Expenses
Receivables	$1.599M	$379.0K	$525.0K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$236.5M	$254.4M	$229.5M
YoY Change	3.33%	10.83%	18.98%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.843M	$3.048M	$2.439M
YoY Change	-6.63%	24.97%	121.73%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$47.40M	$39.80M	$159.5M
YoY Change	-61.77%	-75.05%
Other Assets	$55.00K	$34.00K	$75.00K
YoY Change	-21.43%	-54.67%
Total Long-Term Assets	$50.31M	$42.88M	$162.0M
YoY Change	-60.44%	-73.53%	14627.27%
TOTAL ASSETS
Total Short-Term Assets	$236.5M	$254.4M	$229.5M
Total Long-Term Assets	$50.31M	$42.88M	$162.0M
Total Assets	$286.8M	$297.3M	$391.5M
YoY Change	-19.44%	-24.07%	101.81%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.890M	$3.280M	$12.92M
YoY Change	-62.8%	-74.61%	122.74%
Accrued Expenses	$6.215M	$6.338M	$7.782M
YoY Change	-36.07%	-18.56%	46.83%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due			$400.0K
YoY Change			-92.45%
Total Short-Term Liabilities	$10.11M	$9.618M	$21.08M
YoY Change	-49.92%	-54.37%	27.73%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change			-100.0%
Other Long-Term Liabilities	$441.0K	$300.0K	$221.0K
YoY Change	24.58%	35.75%	-55.8%
Total Long-Term Liabilities	$441.0K	$300.0K	$221.0K
YoY Change	24.58%	35.75%	-75.44%
TOTAL LIABILITIES
Total Short-Term Liabilities	$10.11M	$9.618M	$21.08M
Total Long-Term Liabilities	$441.0K	$300.0K	$221.0K
Total Liabilities	$10.55M	$9.903M	$21.30M
YoY Change	-48.64%	-53.5%	22.4%
SHAREHOLDERS EQUITY
Retained Earnings	-$415.8M	-$400.8M	-$301.6M
YoY Change	22.51%	32.92%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$276.2M	$287.4M	$370.2M
YoY Change
Total Liabilities & Shareholders Equity	$286.8M	$297.3M	$391.5M
YoY Change	-19.44%	-24.07%	101.81%

Cashflow Statement

Concept	2016 Q4	2016 Q3	2015 Q3
OPERATING ACTIVITIES
Net Income	-$14.96M	-$17.03M	-$32.45M
YoY Change	-60.48%	-47.53%	91.43%
Depreciation, Depletion And Amortization	$280.0K	$250.0K	$180.0K
YoY Change	27.27%	38.89%	125.0%
Cash From Operating Activities	-$9.700M	-$12.93M	-$24.93M
YoY Change	-70.53%	-48.13%	117.73%
INVESTING ACTIVITIES
Capital Expenditures	-$80.00K	-$260.0K	-$620.0K
YoY Change	-90.24%	-58.06%	31.91%
Acquisitions
YoY Change
Other Investing Activities	$11.87M	$30.08M	-$57.49M
YoY Change	17.06%	-152.32%	71.77%
Cash From Investing Activities	$11.79M	$29.82M	-$58.11M
YoY Change	26.64%	-151.32%	71.21%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	20.00K	400.0K	-10.00K
YoY Change	-103.92%	-4100.0%	-107.14%
NET CHANGE
Cash From Operating Activities	-9.700M	-12.93M	-24.93M
Cash From Investing Activities	11.79M	29.82M	-58.11M
Cash From Financing Activities	20.00K	400.0K	-10.00K
Net Change In Cash	2.110M	17.29M	-83.05M
YoY Change	-108.75%	-120.82%	83.54%
FREE CASH FLOW
Cash From Operating Activities	-$9.700M	-$12.93M	-$24.93M
Capital Expenditures	-$80.00K	-$260.0K	-$620.0K
Free Cash Flow	-$9.620M	-$12.67M	-$24.31M
YoY Change	-70.03%	-47.88%	121.4%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	0	USD
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-4000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1967000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	152000	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	1000000	USD
	us-gaap	Repayments Of Debt RepaymentsOfDebt	3975000	USD
	us-gaap	Repayments Of Debt RepaymentsOfDebt	0	USD
CY2015Q4	cmrx	Accrued Development Liabilities AccruedDevelopmentLiabilities	3596000	USD
CY2016Q3	cmrx	Accrued Development Liabilities AccruedDevelopmentLiabilities	3236000	USD
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2016
	dei	Document Period End Date DocumentPeriodEndDate	2016-09-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0001117480
CY2016Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	46315425	shares
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	CHIMERIX INC
CY2015Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	10458000	USD
CY2016Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	3280000	USD
CY2015Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2432000	USD
CY2016Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	379000	USD
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-1186000	USD
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-1010000	USD
CY2015Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	9721000	USD
CY2016Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	6338000	USD
CY2015Q4	us-gaap	Accrued Salaries Current And Noncurrent AccruedSalariesCurrentAndNoncurrent	2939000	USD
CY2016Q3	us-gaap	Accrued Salaries Current And Noncurrent AccruedSalariesCurrentAndNoncurrent	2090000	USD
CY2015Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-764000	USD
CY2016Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-366000	USD
CY2015Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	675591000	USD
CY2016Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	688518000	USD
CY2015Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3679000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	8882000	USD
CY2016Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4095000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	12334000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	64000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	0	USD
CY2015Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1100000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1300000	shares
CY2016Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1400000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	900000	shares
CY2015Q4	us-gaap	Assets Assets	355992000	USD
CY2016Q3	us-gaap	Assets Assets	297253000	USD
CY2015Q4	us-gaap	Assets Current AssetsCurrent	228837000	USD
CY2016Q3	us-gaap	Assets Current AssetsCurrent	254370000	USD
CY2015Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	323769000	USD
CY2016Q3	us-gaap	Available For Sale Securities AvailableForSaleSecurities	240116000	USD
CY2015Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	2000	USD
CY2016Q3	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	86000	USD
CY2015Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	766000	USD
CY2016Q3	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	452000	USD
CY2015Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	324533000	USD
CY2016Q3	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	240482000	USD
CY2015Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	0	USD
CY2016Q3	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	0	USD
CY2015Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss	766000	USD
CY2016Q3	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss	452000	USD
CY2015Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue	317521000	USD
CY2016Q3	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue	52209000	USD
CY2015Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	766000	USD
CY2016Q3	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	452000	USD
CY2015Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	317521000	USD
CY2016Q3	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	52209000	USD
CY2015Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	0	USD
CY2016Q3	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	0	USD
CY2015Q4	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	199729000	USD
CY2016Q3	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	200315000	USD
CY2016Q3	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	39801000	USD
CY2016Q3	us-gaap	Available For Sale Securities Debt Maturities Single Maturity Date AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate	238970000	USD
CY2016Q3	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	199169000	USD
CY2015Q4	us-gaap	Available For Sale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Less Than One Year AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsLessThanOneYear	180	securities
CY2016Q3	us-gaap	Available For Sale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Less Than One Year AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsLessThanOneYear	12	securities
CY2015Q4	us-gaap	Available For Sale Securities Noncurrent AvailableForSaleSecuritiesNoncurrent	124040000	USD
CY2016Q3	us-gaap	Available For Sale Securities Noncurrent AvailableForSaleSecuritiesNoncurrent	39801000	USD
CY2015Q4	us-gaap	Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions1 AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions1	180	securities
CY2016Q3	us-gaap	Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions1 AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions1	12	securities
CY2015Q4	us-gaap	Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Greater Than Or Equal To One Year AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsGreaterThanOrEqualToOneYear	0	securities
CY2016Q3	us-gaap	Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Greater Than Or Equal To One Year AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsGreaterThanOrEqualToOneYear	0	securities
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	128462000	USD
CY2015Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	44720000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	20605000	USD
CY2016Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	49358000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-83742000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	28753000	USD
CY2015Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2016Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2015Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2016Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2015Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	46162525	shares
CY2016Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	46315425	shares
CY2015Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	46162525	shares
CY2016Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	46315425	shares
CY2015Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	46000	USD
CY2016Q3	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	46000	USD
CY2015Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-33897000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-79208000	USD
CY2016Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-17123000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-61035000	USD
CY2015Q3	us-gaap	Contracts Revenue ContractsRevenue	2271000	USD
	us-gaap	Contracts Revenue ContractsRevenue	6104000	USD
CY2016Q3	us-gaap	Contracts Revenue ContractsRevenue	653000	USD
	us-gaap	Contracts Revenue ContractsRevenue	3722000	USD
CY2015Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	354000	USD
CY2016Q3	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	285000	USD
	us-gaap	Depreciation Depreciation	444000	USD
	us-gaap	Depreciation Depreciation	781000	USD
CY2015Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.70
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.84
CY2016Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.37
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.33
CY2015Q4	us-gaap	Fair Value Assumptions Exercise Price FairValueAssumptionsExercisePrice	1.54
CY2015Q4	us-gaap	Fair Value Assumptions Expected Dividend Rate FairValueAssumptionsExpectedDividendRate	0
CY2015Q4	us-gaap	Fair Value Assumptions Expected Term FairValueAssumptionsExpectedTerm	P169D
CY2015Q4	us-gaap	Fair Value Assumptions Expected Volatility Rate FairValueAssumptionsExpectedVolatilityRate	0.75
CY2015Q4	us-gaap	Fair Value Inputs Discount For Lack Of Marketability FairValueInputsDiscountForLackOfMarketability	0.10
CY2015Q4	us-gaap	Fair Value Assumptions Risk Free Interest Rate FairValueAssumptionsRiskFreeInterestRate	0.0044
CY2015Q4	us-gaap	Fair Value Investments Entities That Calculate Net Asset Value Per Share Redemption Restriction Period FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareRedemptionRestrictionPeriod	P18M
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3	1114000	USD
CY2015Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8524000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	21812000	USD
CY2016Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5827000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	19359000	USD
CY2015Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2016Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	7931000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-10580000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	419000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2080000	USD
	us-gaap	Increase Decrease In Deferred Liabilities IncreaseDecreaseInDeferredLiabilities	4000	USD
	us-gaap	Increase Decrease In Deferred Liabilities IncreaseDecreaseInDeferredLiabilities	-51000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	5354000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1737000	USD
CY2015Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	299000	USD
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	498000	USD
CY2016Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	396000	USD
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	1146000	USD
	us-gaap	Interest Paid Net InterestPaidNet	156000	USD
	us-gaap	Interest Paid Net InterestPaidNet	0	USD
CY2015Q4	us-gaap	Liabilities Liabilities	20533000	USD
CY2016Q3	us-gaap	Liabilities Liabilities	9903000	USD
CY2015Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	355992000	USD
CY2016Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	297253000	USD
CY2015Q4	us-gaap	Liabilities Current LiabilitiesCurrent	20179000	USD
CY2016Q3	us-gaap	Liabilities Current LiabilitiesCurrent	9618000	USD
CY2015Q3	us-gaap	Licenses Revenue LicensesRevenue	0	USD
	us-gaap	Licenses Revenue LicensesRevenue	1548000	USD
CY2016Q3	us-gaap	Licenses Revenue LicensesRevenue	0	USD
	us-gaap	Licenses Revenue LicensesRevenue	0	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	161858000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	592000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-178809000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	82279000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-66791000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-54118000	USD
CY2015Q3	us-gaap	Net Income Loss NetIncomeLoss	-32449000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-79529000	USD
CY2016Q3	us-gaap	Net Income Loss NetIncomeLoss	-17025000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-61433000	USD
CY2015Q3	us-gaap	Operating Expenses OperatingExpenses	35019000	USD
	us-gaap	Operating Expenses OperatingExpenses	87679000	USD
CY2016Q3	us-gaap	Operating Expenses OperatingExpenses	18074000	USD
	us-gaap	Operating Expenses OperatingExpenses	66301000	USD
CY2015Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-32748000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-80027000	USD
CY2016Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1012000	USD
CY2016Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-17421000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-62579000	USD
CY2015Q3	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	200000	USD
	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	500000	USD
CY2016Q3	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	200000	USD
	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	600000	USD
CY2015Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	3186000	USD
CY2015Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	70000	USD
CY2016Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	34000	USD
CY2015Q3	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-1448000	USD
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	321000	USD
CY2016Q3	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-98000	USD
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	398000	USD
CY2015Q3	us-gaap	Other Than Temporary Impairment Losses Investments Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities	0	USD
	us-gaap	Other Than Temporary Impairment Losses Investments Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities	0	USD
CY2016Q3	us-gaap	Other Than Temporary Impairment Losses Investments Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities	0	USD
	us-gaap	Other Than Temporary Impairment Losses Investments Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities	0	USD
	us-gaap	Payments To Acquire Longterm Investments PaymentsToAcquireLongtermInvestments	212766000	USD
	us-gaap	Payments To Acquire Longterm Investments PaymentsToAcquireLongtermInvestments	50867000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1574000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	763000	USD
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	56294000	USD
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	13990000	USD
CY2015Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2016Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2015Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2016Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2015Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2016Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2015Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2016Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2015Q4	us-gaap	Preferred Stock Value Outstanding PreferredStockValueOutstanding	0	USD
CY2016Q3	us-gaap	Preferred Stock Value Outstanding PreferredStockValueOutstanding	0	USD
CY2015Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	6071000	USD
CY2016Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4318000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	161880000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans	1054000	USD
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans	440000	USD
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Shortterm Investments ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments	90822000	USD
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Shortterm Investments ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments	147899000	USD
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-68000	USD
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	0	USD
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	1003000	USD
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	0	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	USD
CY2015Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3045000	USD
CY2016Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3048000	USD
CY2015Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	26495000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	65867000	USD
CY2016Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	12247000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	46942000	USD
CY2015Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-339414000	USD
CY2016Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-400848000	USD
CY2015Q3	us-gaap	Revenues Revenues	2271000	USD
	us-gaap	Revenues Revenues	7652000	USD
CY2016Q3	us-gaap	Revenues Revenues	653000	USD
	us-gaap	Revenues Revenues	3722000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	8882000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	12334000	USD
CY2016Q3	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	0	shares
	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	0	shares
CY2015Q4	us-gaap	Stockholders Equity StockholdersEquity	335459000	USD
CY2016Q3	us-gaap	Stockholders Equity StockholdersEquity	287350000	USD
CY2016Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD
CY2015Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	46059112	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	43112314	shares
CY2016Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	46236749	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	46211748	shares

Files In Submission

Name	View Source	Status
0001117480-16-000056-index-headers.html	Edgar Link	pending
0001117480-16-000056-index.html	Edgar Link	pending
0001117480-16-000056.txt	Edgar Link	pending
0001117480-16-000056-xbrl.zip	Edgar Link	pending
a20160930cmrx10-qdocument.htm	Edgar Link	pending
a20160930cmrxex-101.htm	Edgar Link	pending
a20160930cmrxex-102.htm	Edgar Link	pending
a20160930cmrxex-311.htm	Edgar Link	pending
a20160930cmrxex-312.htm	Edgar Link	pending
a20160930cmrxex-321.htm	Edgar Link	pending
a20160930cmrxex-322.htm	Edgar Link	pending
cmrx-20160930.xml	Edgar Link	completed
cmrx-20160930.xsd	Edgar Link	pending
cmrx-20160930_cal.xml	Edgar Link	unprocessable
cmrx-20160930_def.xml	Edgar Link	unprocessable
cmrx-20160930_lab.xml	Edgar Link	unprocessable
cmrx-20160930_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CMRX
CHIMERIX INC Stock $cmrx

2016 Q4 Form 10-Q Financial Statement

#000111748016000056 Filed on November 07, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CMRX CHIMERIX INC Stock $cmrx

2016 Q4 Form 10-Q Financial Statement

#000111748016000056 Filed on November 07, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CMRX
CHIMERIX INC Stock $cmrx